BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29735511)

  • 1. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.
    Diaz-Manera J; Fernandez-Torron R; LLauger J; James MK; Mayhew A; Smith FE; Moore UR; Blamire AM; Carlier PG; Rufibach L; Mittal P; Eagle M; Jacobs M; Hodgson T; Wallace D; Ward L; Smith M; Stramare R; Rampado A; Sato N; Tamaru T; Harwick B; Rico Gala S; Turk S; Coppenrath EM; Foster G; Bendahan D; Le Fur Y; Fricke ST; Otero H; Foster SL; Peduto A; Sawyer AM; Hilsden H; Lochmuller H; Grieben U; Spuler S; Tesi Rocha C; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Harms M; Pestronk A; Krause S; Schreiber-Katz O; Walter MC; Paradas C; Hogrel JY; Stojkovic T; Takeda S; Mori-Yoshimura M; Bravver E; Sparks S; Bello L; Semplicini C; Pegoraro E; Mendell JR; Bushby K; Straub V;
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1071-1081. PubMed ID: 29735511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
    Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern.
    Llansó L; Moore U; Bolano-Diaz C; James M; Blamire AM; Carlier PG; Rufibach L; Gordish-Dressman H; Boyle G; Hilsden H; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Pestronk A; Walter MC; Paradas C; Stojkovic T; Mori-Yoshimura M; Bravver E; Pegoraro E; Mendell JR; Straub V; Díaz-Manera J
    Neuromuscul Disord; 2023 Apr; 33(4):349-357. PubMed ID: 36972667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseases.
    Bolano-Diaz C; Verdú-Díaz J; Gonzalez-Chamorro A; Fitzsimmons S; Veeranki G; Straub V; Diaz-Manera J
    Neuromuscul Disord; 2024 Jan; 34():54-60. PubMed ID: 38007344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous characteristics of MRI changes of thigh muscles in patients with dysferlinopathy.
    Jin S; Du J; Wang Z; Zhang W; Lv H; Meng L; Xiao J; Yuan Y
    Muscle Nerve; 2016 Dec; 54(6):1072-1079. PubMed ID: 27251469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadening the imaging phenotype of dysferlinopathy at different disease stages.
    Díaz J; Woudt L; Suazo L; Garrido C; Caviedes P; CÁrdenas AM; Castiglioni C; Bevilacqua JA
    Muscle Nerve; 2016 Aug; 54(2):203-10. PubMed ID: 26800485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease duration and disability in dysfeRlinopathy can be described by muscle imaging using heatmaps and random forests.
    Gómez-Andrés D; Díaz J; Munell F; Sánchez-Montáñez Á; Pulido-Valdeolivas I; Suazo L; Garrido C; Quijano-Roy S; Bevilacqua JA
    Muscle Nerve; 2019 Apr; 59(4):436-444. PubMed ID: 30578674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
    Reyngoudt H; Smith FE; Caldas de Almeida Araújo E; Wilson I; Fernández-Torrón R; James MK; Moore UR; Díaz-Manera J; Marty B; Azzabou N; Gordish H; Rufibach L; Hodgson T; Wallace D; Ward L; Boisserie JM; Le Louër J; Hilsden H; Sutherland H; Canal A; Hogrel JY; Jacobs M; Stojkovic T; Bushby K; Mayhew A; ; Straub V; Carlier PG; Blamire AM
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1850-1863. PubMed ID: 35373496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological correlations and fat replacement imaging patterns in recessive limb-girdle muscular dystrophy type 12.
    De Wel B; Huysmans L; Depuydt CE; Goosens V; Peeters R; Santos FP; Thal DR; Dupont P; Maes F; Claeys KG
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1468-1481. PubMed ID: 37078404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging pattern variability in dysferlinopathy.
    Bardakov SN; Tsargush VA; Carlier PG; Nikitin SS; Kurbatov SA; Titova AA; Umakhanova ZR; Akhmedova PG; Magomedova RM; Zheleznyak IS; Emelyantsev AA; Berezhnaya EN; A Yakovlev I; Isaev AA; Deev RV
    Acta Myol; 2021 Dec; 40(4):158-171. PubMed ID: 35047756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A>G in the
    Xie Z; Xiao J; Zheng Y; Wang Z; Yuan Y
    Biomed Res Int; 2018; 2018():3710814. PubMed ID: 30003095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies.
    ten Dam L; van der Kooi AJ; van Wattingen M; de Haan RJ; de Visser M
    Neurology; 2012 Oct; 79(16):1716-23. PubMed ID: 23035061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases.
    Reyngoudt H; Marty B; Boisserie JM; Le Louër J; Koumako C; Baudin PY; Wong B; Stojkovic T; Béhin A; Gidaro T; Allenbach Y; Benveniste O; Servais L; Carlier PG
    Eur Radiol; 2021 Jun; 31(6):4264-4276. PubMed ID: 33219846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty infiltration evaluation and selective pattern characterization of lower limbs in limb-girdle muscular dystrophy type 2A by muscle magnetic resonance imaging.
    Feng X; Luo S; Li J; Yue D; Xi J; Zhu W; Gao X; Guan X; Lu J; Liang Z; Zhao C
    Muscle Nerve; 2018 Oct; 58(4):536-541. PubMed ID: 29797799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water T2 could predict functional decline in patients with dysferlinopathy.
    Moore U; Caldas de Almeida Araújo E; Reyngoudt H; Gordish-Dressman H; Smith FE; Wilson I; James M; Mayhew A; Rufibach L; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Pestronk A; Walter MC; Paradas C; Stojkovic T; Mori-Yoshimura M; Bravver E; Pegoraro E; Mendell JR; ; Bushby K; Blamire AM; Straub V; Carlier PG; Diaz-Manera J
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2888-2897. PubMed ID: 36058852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical and MRI follow-up in two POMT2-related limb girdle muscular dystrophy (LGMDR14) patients.
    Panicucci C; Casalini S; Damasio BM; Brolatti N; Pedemonte M; Biolcati Rinaldi A; Morando S; Doglio L; Raffaghello L; Fiorillo C; Zara F; Tasca G; Bruno C
    Brain Dev; 2023 May; 45(5):306-313. PubMed ID: 36797079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric quantitative MRI assessment of thigh muscles in limb-girdle muscular dystrophy 2A and 2B.
    Arrigoni F; De Luca A; Velardo D; Magri F; Gandossini S; Russo A; Froeling M; Bertoldo A; Leemans A; Bresolin N; D'angelo G
    Muscle Nerve; 2018 Oct; 58(4):550-558. PubMed ID: 30028523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes.
    Díaz-Manera J; Alejaldre A; González L; Olivé M; Gómez-Andrés D; Muelas N; Vílchez JJ; Llauger J; Carbonell P; Márquez-Infante C; Fernández-Torrón R; Poza JJ; López de Munáin A; González-Quereda L; Mirabet S; Clarimon J; Gallano P; Rojas-García R; Gallardo E; Illa I
    Neuromuscul Disord; 2016 Jan; 26(1):33-40. PubMed ID: 26573435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.